Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain
the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in
Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles
and JavaScript.
When Australian biotechnologists sit down to discuss the future of their industry, size is inevitably on the agenda. Australia may be a large country, but its population is just half the size of that of California. Niall Byrne looks at how Australia's small companies could assert themselves, despite being the underdogs.
Biotech companies are exploring Australia's unique ecosystems in search of novel compounds for the next generation of pharmaceuticals and chemical agents. David Blake profiles the companies built on Australia's biodiversity.
The Australian biotechnology industry is itching to grow up. Despite decades of world-class discoveries in science, it is a young industry by world standards, and is just starting to find its commercial feet. Charles Beckley reports.
Is the future of agriculture in biopharming, an industry that uses modified crops to grow pharmaceuticals or foods with enhanced health benefits? Brad Collis investigates how the Australian industry is carving out a niche for itself.
Biomedical research in Australia may have chalked up some successes, but it has also let some money-spinning ideas slip through its fingers. Having learned its lesson, this nascent industry is now beginning to flex its muscles. David Blake reports.
